Reassuringly, the BCR pathway, a key highlight, together with MAPK, mTOR, T-cell receptor (TLR), and NFκB pathways, known to be associated with CLL cell signaling, were identified. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.